Aksu Tolga, Guler Tumer, Yalin Kivanc, Golcuk Sukriye Ebru, Ozcan Kazim
Department of Cardiology, Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey.
Department of Cardiology, Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey.
Am J Med Sci. 2016 Nov;352(5):466-471. doi: 10.1016/j.amjms.2016.08.025. Epub 2016 Sep 21.
Septal reduction therapy is the gold standard treatment method for symptomatic, hypertrophic obstructive cardiomyopathy. Although surgical myectomy is a well-established and effective technique with decades of experience in its application, use of transcoronary alcohol septal ablation has increased precipitously owing to the less-invasive nature of the procedure. Moreover, endocardial septal ablation therapy is a relatively newly defined modality, and outcomes of the procedure are not clearly elucidated yet. In this review, we aimed to present nonsurgical septal reduction approaches in patients with hypertrophic obstructive cardiomyopathy.
室间隔减容治疗是有症状的肥厚性梗阻性心肌病的金标准治疗方法。虽然外科室间隔心肌切除术是一种成熟且有效的技术,已有数十年的应用经验,但由于经冠状动脉酒精室间隔消融术的侵入性较小,其使用量急剧增加。此外,心内膜室间隔消融治疗是一种相对较新定义的治疗方式,该治疗方式的结果尚未明确阐明。在本综述中,我们旨在介绍肥厚性梗阻性心肌病患者的非手术性室间隔减容方法。